Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 11 Mar 2026 Tres pastillas para eliminar la enfermedad del sueño en un contexto de recortes globales en ayuda al desarrollo El País
In the media 10 Mar 2026 Entretien avec Dr Hélène Mahenzi à propos d’un nouveau médicament développé contre la maladie du sommeil RFI Priorité Santé
In the media 9 Mar 2026 Falta de medicamentos, centros médicos destruidos y recortes: cómo la guerra en Sudán ha golpeado a las enfermedades más olvidadas El País
In the media 2 Mar 2026 Europa da el visto bueno a una terapia más sencilla contra la enfermedad del sueño La Razon
In the media 27 Feb 2026 ‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication Science
In the media 27 Feb 2026 La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement France 24
In the media 27 Feb 2026 Maladie du sommeil : l’autorisation européenne d’un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030 Le Monde
In the media 27 Feb 2026 New sleeping sickness pill gets nod, paving the way for use in Africa Associated Press
In the media 27 Feb 2026 Single-dose sleeping sickness pill clears major EU regulatory milestone Capital FM
In the media 27 Feb 2026 EMA gives positive opinion for single-dose sleeping sickness medication Citizen Digital
In the media 27 Feb 2026 After CHMP nod, Moderna CEO applauds EU’s ‘rigorous scientific review’ Fierce Pharma
